NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

PORTHOS - PORTuguese Heart Failure Observational Study
PORTHOS - PORTuguese Heart Failure Observational Study

NCT05434923

CompletedN/A

Sponsor: AstraZeneca

Conditions: Heart Failure

Countries: Portugal

This study aims to determine the prevalence of heart failure in the resident population in mainland Portugal aged 50 years or above, using a contemporary, guideline-based diagnostic approach, to optimize patient management and improve strategic healthcare decision-making

Eligibility overview

Sex: ALL

Age: 50 Years to

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Community-dwelling citizens living in Mainland Portugal;
* Registration in a primary care centre;
* Age ≥50 years at recruitment;
* Voluntary signed informed consent.

Exclusion criteria:

* Living in institutions (e.g., nursing homes, prisons, military facilities, hospitals);
* Non-Portuguese speakers;
* Reduced physical and/or cognitive ability hampering participation (e.g., blindness, deafness, or cognitive impairment).
Locations (13)
  • Aljustrel, Portugal
  • Aveiro, Portugal
  • Braga, Portugal
  • Castelo Branco, Portugal
  • Coimbra, Portugal
  • Lagos, Portugal
  • Lisbon, Portugal
  • Porto, Portugal
  • Serpa, Portugal
  • Setúbal, Portugal
  • Silves, Portugal
  • Sobral de Monte Agraço, Portugal
  • Torres Vedras, Portugal